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Letter 
Enterobacter cloacae is a clinically important gram-negative member of the 
Enterobacteriaceae, which has increasingly been recognised as a major pathogen in 
nosocomial infections. Despite this, knowledge about the population structure and the 
distribution of virulence factors and antibiotic resistance determinants of this species is 
scarce.  In this study, we analysed a systematic collection of multidrug resistant E. cloacae 
isolated between 2001 and 2011 from bloodstream infections across hospitals in the UK and 
Ireland. We found that the population is characterized by the presence of multiple clones 
formed at widely different time periods in the past. The clones exhibit a high degree of 
geographical heterogeneity, which indicates extensive dissemination of these E. cloacae 
clones across the UK and Ireland. These findings suggest that a diverse, community-based, 
commensal population underlies multidrug resistant E. cloacae infections within hospitals.  
 
Enterobacter cloacae is a non-motile bacterium that belongs to the Enterobacteriaceae 
family. E. cloacae have been recovered from natural environments 1-3. In addition, E. cloacae 
is an opportunistic pathogen that can cause a wide range of infections, in particular in 
immune-compromised individuals. E. cloacae has been increasingly recognized as a cause of 
hospital-acquired infections and outbreaks in the past few decades 4-6, as reported in 
hospitals 7,8, especially in the neonatal settings 9. The reservoirs for E. cloacae in hospitals 
are thought to include equipment, cleaning solutions and healthcare workers 9-11. 
Furthermore, endogenous infection from an established clone carried by individuals prior to 
admission to hospital has also been described. Multi-locus sequencing typing (MLST) has 
shown that the global E. cloacae population is highly diverse, and includes a limited number 
of clonal complexes that have spread internationally and independently acquired antibiotic 
resistance elements 12,13.  
 
A number of antibiotic resistance genes, and to a lesser extent pathogenicity mechanisms, of 
E. cloacae have been elucidated to date 5,14-17. Multiple virulence factors and extended 
spectrum beta-lactamases (ESBLs) or the hyper-production of constitutive AmpC beta-
lactamase have been shown to be involved in the development of infection and 
antimicrobial resistance, respectively 6. Furthermore previous genomic studies have shown 
that the E. cloacae genome harbours a large repertoire of accessory genetic elements that 
enable colonization of diverse environments and efficient metabolic adaptation to different 
niches and environmental stresses 6,18-20. 
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There is a growing recognition that E. cloacae is now the third major Enterobacteriaceae 
species involved in nosocomial infections after Escherichia coli and K. pneumoniae. To 
understand the spread of multidrug-resistant pathogens within the population it is 
necessary to determine their epidemiology and population structure. However, unlike other 
important pathogens, our knowledge about the population genomics of E. cloacae is limited. 
To fill this gap, we utilized whole genome sequencing of a large systematic collection of 
multidrug resistant (MDR) E. cloacae collected from various hospitals across the UK between 
2001 and 2011.  
 
Our collection contained 316 genomes composed of MDR E. cloacae collected from 37 
hospitals in the UK and Ireland between 2001 and 2011. We first calculated the set of core 
genes (genes shared by every member of the population) and accessory genes (genes that 
were variably present between isolates). De-novo assembly and annotation of core and 
accessory genomes showed that the pan-genome of E. cloacae contained 44,235 genes, 
1,567 and 490 of which were in the hard core (genes present in >99% of samples) and the 
soft core genome (genes present in >95% and <99% of samples), respectively. This large 
number of accessory genes indicates a very high degree of flexibility of the E. cloacae 
genome, which reflects the diverse environmental habitats that this bacterium occupies. The 
core genome was ~1.5 Mbp. We found a high degree of congruence between the pattern of 
the presence and absence of accessory genes and the genetic distance between the core 
genomes in our dataset (p < 0.001, Mantel test) suggesting that the MDR clones of which the 
data set comprises were each formed with a distinct subset of genes which have undergone 
little change since the clone emerged (Supplementary Figure 1 A).  
 
The distribution of pairwise SNP distances between isolates showed that the population of 
MDR isolates was highly structured and composed of closely-related clades together with 
strains that were far more distantly related to other isolates in the collection (Figure 1A and 
Figure 1B). In line with this, the phylogenetic tree constructed from the core genome variant 
sites showed that the population consisted of one large primary group with a number of 
closely related sub-populations (clones) nested within it, and a divergent clade that mainly 
contained individual isolates that, according to rpoB and hsp60 typing 21, represent separate 
sub-species in the E. cloacae complex including Enterobacter asburiae and Enterobacter 
kobei (Supplementary Figure 1 B and 1 C in Supplementary Material). We observed a low 
degree of geographic clustering in the tree, and the high level of diversity of the species was 
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also reflected in the number of different MLST sequence types (STs) that made up the 
population, some of which are the most widespread STs in a global collection of E. cloacae 
13. This suggests that isolates in our collection are part of a global circulation of these clones 
(Supplementary Figure 2 in Supplementary Material). 
 
In order to investigate the recent evolution of E. cloacae in greater detail, we analysed the 
major clones in our collection. Utilizing the clustering method detailed in the methods 
section, we identified 11 distinct groups that contained more than 9 isolates (Figure 2A). We 
found that isolates in these groups could be adequately identified by MLST since most 
clusters contained a single sequence type (Figure 2B, Supplementary Notes 2 in 
Supplementary Material). As with the whole tree, the clones exhibited a high level of 
geographical diversity in that the majority of the clusters contain isolates originating from 
multiple hospitals (Figure 2C). Furthermore, and in line with this, the distribution of the 
pairwise geographical distances between isolates within each clone were as widespread as 
those within the whole collection for the majority of clones, and only for clones 14, 2 and 13 
was the geographical clustering significant (p <0.01, one-sided t-test < 0.01) (Figure 2D). This 
implies that, prior to the time of the study, the dissemination of all the different E. cloacae 
MDR clones appeared to have already taken place across the country.  
 
Utilizing the variation within the time of isolation within each cluster (Figure 2E), we 
estimated the substitution rate for the genome for those clusters where there was a 
detectable signal to be between 0.5 and 3 SNPs per genome per year (an average of 1.5 x 10-
7 SNPs per site per year across the genome) (Supplementary Figures 3 A and S 4 in 
Supplementary Material). These calculations indicate that these clusters were established 
between ~10 and ~150 years ago (Supplementary Figure 3 B). Using the average substitution 
rate, and applying it to the other major clusters for which we could not detect a temporal 
signal, we calculated the root age for these clusters to be between 50 and 250 years ago 
(Supplementary Figure 3 B and 4 in Supplementary Material). We conclude that drug 
resistant E. cloacae clones have been continuously arising and expanding over the past 
several decades.  Subsequently, we used these substitution rates to estimate the dates and 
numbers of putative recent relationships of isolates in different hospitals. To this end we 
extracted all the pairs of isolates that were less than 40 SNPs apart (which corresponds to 
~20 years). We found that these isolates originated from different hospitals across the 
country, and when we compared the geographical distances between these linked hospitals 
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with the distribution of pairwise geographical distance for the whole collection we found no 
significant difference (p > 0.05, one-sided t-test) (Supplementary Figure 3 C in 
Supplementary Material). The results demonstrate that inter-hospital connectivity between 
genetically similar isolates exists, but that this is not necessarily between geographically 
close hospitals (Supplementary Figure 3 C in Supplementary Material). To further examine 
this finding, we reconstructed the networks for all SNP cutoffs since the most recent clone 
(clone 7) emerged in the population. Our results show that although the proportion of inter-
hospital relationships decreased with stricter cut-off values, the number of isolates in the 
network also declined rapidly (Supplementary Figure 5 in Supplementary Material). The 
findings show that even with 316 samples the population is still so diverse that only a very 
few recent close relationships can be detected.  
 
Within the population, we were able to identify the differential presence of multiple 
plasmids and putative virulence factors, some of which were clade specific, implying that the 
population of E. cloacae has developed both conserved and variable virulence mechanisms 
(Supplementary Notes 4 and 5 in Supplementary Material). Furthermore our antimicrobial 
resistance analysis demonstrated various patterns of emergence of antimicrobial resistance 
determinants in the collection, where resistance determinants were acquired independently 
throughout the population (Supplementary Notes S6 in Supplementary Material). This 
implies a potential for rapid adaptability in E. cloacae. The observations of the antimicrobial 
resistance analysis are particularly important since the emergence of antibiotic resistance 
for the currently effective antibiotics such as imipenem, tigecycline and ciprofloxacin raises 
concerns that the resistance profile may extend in the future, in particular through mobile 
genetic elements. Moreover, the commensal nature of the bacterial population documented 
here will allow rapid spread of resistant E. cloacae throughout the human population, 
outside of hospital-based infection control, from which it can readily be imported into 
hospitals.  
 
The dissemination of E. cloacae raises questions about the underlying reservoirs and routes 
of the spread of pathogens between hospitals. A diverse range of sources, including 
healthcare staff and equipment, waste waster and food have been shown to serve as 
reservoirs of E. cloacae 2,3,22. Despite being the largest genomic collection of E. cloacae 
studied to date, our collection only contained clinical isolates so we are not able to draw a 
definitive conclusion about the sources and potential reservoirs of E. cloacae.  However the 
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relationship between our isolates and previously published E. cloacae genomes indicates 
that clinical and non-clinical strains originating from the USA, India and China are scattered 
throughout our phylogeny, both within and outside the clones identified here 
(Supplementary Figure 17). Clinical isolates recovered from a systematic screen of infections 
in a single hospital in the USA 23 were also spread across the tree, although mainly in the 
rarer sub-species. An environmental isolate recovered from oil-contaminated soil in India 24, 
a food borne isolate from pepper 19 in Hong Kong and an isolate of plant infection origin 20 
were also mainly in the rarer sub-species. Together, this suggests that the broad diversity of 
E. cloacae causing infections in the UK may be part of a global population transmitting via 
different routes involving both clinical and non-clinical sources. To fully elucidate this, a 
more comprehensive collection, containing isolates of different non-clinical and clinical 
origins is required, which would serve as the basis for future genomic studies on E. cloacae. 
 
Enterobacter infections can be acquired within a hospital or originate from a pathogen 
within an already colonized patient. Although there are reports tracing infections to the 
contamination of hospital devices, most of the infections reported previously do not appear 
to have a common nosocomial source and may be accounted for by previously established 
clones within patients 25,26. Our findings are consistent with diverse sources of E. cloacae in 
any individual hospital. The close genetic relationship between isolates from different 
geographic regions that was frequently observed suggest that individuals that have already 
been colonised before entering hospital introduce multiple strains into hospitals, some of 
which may be involved in subsequent intra-hospital transmissions. Isolates from hospital 
infections therefore represent samplings from the diversity of commensal E. cloacae in the 
community. In this sense the apparent spread of E. cloacae between the hospitals found 
here may only mirror the dissemination of this species throughout the UK and Ireland. The 
presence of some isolates from the known major globally circulating STs, as well as the close 
genetic distance between isolates of different source and country of origins, indicate that 
the geographical distribution of E. cloacae lineages goes beyond UK and Ireland and belongs 
to a global population 7. From this, it is apparent that controlling E. cloacae infections may 
be more difficult than other nosocomial pathogens, where within-hospital transmission is 
often the primary source of new infections.    
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METHODS 
Isolates and antimicrobial susceptibility testing  
The study was approved by the National Research Ethics Service (ref: 12/EE/0439) and the 
CUH Research and Development (R&D) Department. We studied a national collection of 316 
E. cloacae isolates that were collected as part of the British Society for Antimicrobial 
Chemotherapy (BSAC) Resistance Surveillance project (www.bsacsurv.org). The collection 
was part of a bacteraemia surveillance programme (all isolates were from blood of patients 
with blood infection) that ran between 2001-2011 in 37 hospitals across the United Kingdom 
and Ireland (UK&I). The strains were identified to species level using API20E strips and the 
species were further confirmed using Kraken 27. Selection for the collection was based on 
the presence of phenotypic resistance to at least 4 antimicrobial groups. We provide a list of 
isolates in Supplementary Table 1.  
 
Antimicrobials that were tested in this study were beta-lactams (penicillin: amoxicillin, 
cephalosporins: cefuroxime, cefoxitin, cefotaxime, ceftazidime, and piperacillin-tazobactam 
and amoxicilin-clavulanic acid), tetracyclines (minocycline, tetracycline and tigecycline), 
aminoglycosides (gentamicin) and fluoroquinolones (ciprofloxacin). We defined Multidrug 
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resistance (MDR) as acquired non-susceptibility to at least one agent in three or more 
antimicrobial categories, as it is proposed in 28. We then selected Isolates based on the 
presence of phenotypic resistance to at least one antimicrobial in three of the antimicrobial 
groups: penicillins, carbapenems, cephalospsorins, tetracyclines, aminoglycoside and 
fluoroquinolones.  
 
The minimum inhibitory concentration (MIC) for each antimicrobial agent was determined 
using the BSAC agar dilution method. To obtain an insight into the distribution of MIC values, 
we compared the distribution of MIC values of our samples with those from the European 
Committee on Antimicrobial Susceptibility Testing (EUCAST). We obtained these 
distributions and also the clinical susceptibility breakpoints to determine resistance from the 
EUCAST website (www.eucast.org) on 02/02/2016.  
 
Sequencing, pan-genome and phylogenetic analysis 
DNA was extracted using a QIAxtractor (QIAgen), according to the manufacturer’s 
instructions. Sequencing libraries were constructed as described by the manufacturer 
(http://www.illumina.com/techniques/sequencing/ngs-library-prep). The sequencing was 
conducted on an Illumina HiSeq2000 with a read length of 2X100 bp. 96 samples were 
multiplexed per lane to give an average depth of coverage of 71-fold.  The assembled data 
and raw sequences were deposited in the ENA under the accession numbers provided in 
Supplementary Table 1. We assembled paired end sequence reads using an in-house 
assembly and improvement pipeline 29, based on Velvet 30. Subsequently we annotated the 
assemblies with Prokka, which takes fragmented de novo assemblies 31. We then used the 
annotated assemblies produced by Prokka as input to Roary, a tool that rapidly builds large-
scale pan-genomes, to construct the core and accessory genome 32 (One isolate was 
excluded from pan-genome analysis, as it fell outside Roary’s similarity cut-offs). To estimate 
a Maximum Likelihood tree, we employed FastTree version 2.1.3 with generalized time-
reversible model to reconstruct the phylogenetic tree from the core genome alignment 33. 
We assessed the confidence values through SH-like support. To visualize trees and 
associated metadata, we used FigTree (http://tree.bio.ed.ac.uk/software/figtree/), 
Dendroscope 3 34 and in-house tools.  
 
Divergence analysis and cluster analysis  
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In addition to phylogenetic analysis we reconstructed the network of relatedness between 
the isolates using the SeqTrack algorithm function in R package adegenet 35,36. The algorithm 
reconstructs ancestries between the sequences, by considering the genetic distances and 
isolation dates, to obtain a tree with maximum parsimony. In Supplementary Figure 3, we 
included the network in which the edges that correspond to >40 SNPs, i.e. the number of 
variant sites in the core genome alignment, were excluded. Given the estimated substitution 
rate of E. cloacae, 40 SNPs is equivalent to SNPs accumulated over approximately ~20 years 
(see main text). To identify the clusters in the phylogenetic tree, we used the clustering 
algorithm detailed in the adegenet package. The distance-based clustering algorithm takes 
the pairwise SNP distance matrix and a SNP cut-off to identify the clones.  We tested various 
SNP cut-off values from 0, producing 315 clusters, to very large values, which collapses the 
entire sample set into one cluster. To find the best cut-off for clustering we first excluded 14 
outliers, i.e. the isolates that were very distantly related to other isolates in the collection, 
and then varied the SNP cutoffs while measuring the number of clusters identified. The 
longest plateau where the clustering did not change extended for 3356 SNPs, and this 
yielded 88 clusters We then used the 11 clusters with more than 9 members, including 194 
isolates in total, for downstream analysis.  
 
To assess the output of the clustering method, we compared the result with the output of 
HierBAPS, which performs Bayesian analysis of population structure to cluster similar 
genomic sequences, using 2 clustering iterations and 10, 30 and 50 expected number of 
clusters (k) as input parameters.  Our clusters are strongly in agreement with the clusters of 
the second iteration of BAPS clustering (Supplementary Figure 18).  
 
 
Phylogenetic analysis and substitution rate calculation  
After identifying major clusters on the tree we attempted to estimate the recent nucleotide 
substitution rate. For the nucleotide substitution rate estimation, we first employed Gubbins 
37 to remove high SNP density regions, which signified putative recombination events, from 
the multiple alignment for each cluster. We then reconstructed the tree for each cluster and 
plotted root-to-tip distance versus year of isolation for each sample. Subsequently we 
conducted 10,000 bootstraps with re-sampled years to obtain a distribution for R-squared 
values. We then compared the real R-squared values with the distribution to check the 
significance of the temporal signal in each cluster. We found a strong temporal signal for 
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cluster 8 and weaker signals for clusters 7, 18 and 31. Subsequently we used the BEAST v1.7 
package to obtain the substitution rate and the age of the root node for the clusters with a 
signal 38.  
 
We tested various models including a strict molecular clock (uniform prior distribution for 
the clock rate model) and a log-normal model with constant population model. For each 
parameter set we performed 100 million generations with sampling every 10 generations for 
three times. Besides checking that different runs had converged on similar values, we also 
assessed the convergence for each model by ensuring that ESS values were greater than 200 
for key parameters. A burn-in of 10 million states was discarded from each of the three runs. 
Since the log-normal clock model always converged, we included the results of this model in 
the manuscript. We took the age of the root as the height of the root of the Maximum Clade 
Credibility (MCC) tree reconstructed by combining trees using tree annotator program from 
the BEAST package.  
 
Molecular Typing of E. cloacae complex, in silico MLST analysis and identification of 
antimicrobial resistance determinants, virulence factors and plasmids  
Using the srst2 package 39, we mapped the paired-end reads to resistance, and plasmid 
replicon genes in the databases detailed in the srst2 package (coverage cut-off 90%). We 
also used srst2 to find virulence genes in the Virulence Factors Database (VFDB) 
(http://www.mgc.ac.cn/VFs/main.htm) in the isolates. We then visualized the genes across 
the phylogenetic tree using an in-house tool. We determined the STs of the samples using an 
in silico MLST in-house script that uses the assemblies as input. Furthermore, we conducted 
the rpoB and hsp60 (groL) typing of E. cloacae complex to detect sub-species of E. cloacae 
within our dataset 21. To this end, gene sequences for rpoB and hsp60 (groL) were extracted 
from the assembled genomes. These were then trimmed and compared to the reference set 
21. After phylogenetic estimation with RAxML using a general time reversible (GTR) 
evolutionary model and a gamma correction for among site rate variation 40, isolates were 
allocated to the different clusters based on the reference dataset. This grouping was then 
compared back to the whole-genome phylogeny and clustering. 
 
Regression analysis to identify antimicrobial resistance determinants 
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We developed three linear regression models to identify genetic determinants that are 
strongly associated with resistance. To this end we used MIC values as a continuous 
dependent variable in the linear regression models, instead of the categorical 
resistant/susceptible status. This is because MIC values enabled us to identify the effect of 
different genetic elements even when all samples are classed as resistant. Moreover, the 
MIC values have a higher variance than the categorical resistance status and therefore 
provide more information and allow greater statistical confidence in the results. 
 
In the first linear regression model, we took the MIC values for different antimicrobials as a 
continuous dependent variable and the presence/absence of individual accessory genes as a 
categorical predictor variable. By doing so we aimed to identify genes in the accessory 
genome that are strongly associated (p-value<10-5) with resistance level. 
 
We performed two types of SNP based regression analysis. We first identified genes in which 
the number of non-synonymous SNPs strongly correlates with resistance levels and 
identified individual SNPs, the presence of which are strongly associated with MIC levels. To 
this end, we mapped the short reads against the reference genome E. cloacae ATCC 13047 
(accession number: CP001918) using SMALT v0.7.4 
(https://www.sanger.ac.uk/resources/software/smalt/). The annotation of SNPs was done 
with an in-house script that combines SAMtools mplieup 41 and BCFtools as detailed in 42 (7 
isolates were excluded from the SNP analysis). The SNP association regression model 
identified known/putative resistance SNPs that were strongly correlated with MIC values (p-
value<10-5) primarily for ciprofloxacin. Samples in which SNPs were absent or unknown were 
excluded from the analysis for each site. We also excluded the sites in which more than 10% 
of nucleotides across the population were unknown. In the linear regression model we 
considered MIC values as continuous dependent variable and the presence/absence of 
individual SNPs as a categorical predictor variable. In our second SNP-based analysis, we 
aimed to find genes with a strong correlation between their non-synonymous variation 
pattern and MIC. To this end we developed a linear regression model in which the MIC 
values for different antimicrobials were considered as the continuous dependent variable 
and the number of non-synonymous SNPs in individual genes was used as the continuous 
predictor variable. In all of the above regression models, we accounted for the population 
structure by including the MLST information as the categorical predictor variable into the 
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regression models. We set a stringent p-value of 10-5 to define strong associations and then 
screened the hit list of strongly associated genes/SNPs for putative resistance genes/SNPs. 
 
We have provided the output files of pan-genome analysis, the input and R code for the 
three regression models in a public repository 
(https://data.mendeley.com/datasets/vg6cnk9bc5/1). We have also included the hit lists for 
the three regression models as Supplementary Tables 2, 3 and 4.  
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Figures  
 
 
Figure 1 A) Histogram of pair-wise SNP distance between the core genome sequences of 
isolates. B) Maximum Likelihood tree for the isolates. The colours of the isolates correspond 
to hospitals of isolation. 
 
 
 
 
 
 
 
 
 
 
A
B
30000 SNPs
 13 
 
 
 
 
 
 
 
 
 
Figure 2 A) Detected clusters (CLs) represented on the phylogenetic tree. The intensity of 
branch colour corresponds to the bootstrap support (SH support). B) MLST sequence type 
(ST) composition of each of the clusters. Each colour signifies one ST. C) Hospitals from 
which isolates in each cluster were identified. D) Distribution of pairwise geographical 
distance for each cluster compared with the distribution of the whole population. The 
notched area shows the 95% confidence interval around the median. E) Distribution of the 
time of isolation for isolates in each cluster. The boxes in D) and E) give the interquartile 
range, the whiskers indicate the boundary of 1.5 times the interquartile range, and the 
points beyond that are outliers. 
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